These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 647626)

  • 1. The effects of treatment on delayed cutaneous hypersensitivity responses (DNCB, croton oil, and recall antigen) in patients with genitourinary cancer.
    Elhilali MM; Brosman SA; Vescera C; Paul JG; Fahey JL
    Cancer; 1978 May; 41(5):1765-70. PubMed ID: 647626
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous response to dinitrochlorobenzene in patients with genito-urinary cancers.
    Duclos H; Schwarzenberg L; Duclos SH; Hugues H; Kuss R
    Biomedicine; 1977 Jan; 27(1):43-7. PubMed ID: 856314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin testing in genitourinary carcinoma: 2-year followup.
    Decenzo JM; Allison R; Leadbetter GW
    J Urol; 1975 Aug; 114(2):271-3. PubMed ID: 1171996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response in bladder cancer patients.
    Brosman S; Elhilali M; Vescera C; Fahey J
    J Urol; 1979 Feb; 121(2):162-9. PubMed ID: 423328
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum ribonuclease in urologic cancer. Relation to host immunocompetence.
    Catalona WJ; Chretien PB; Matthews WJ; Tarpley JL
    Urology; 1973 Nov; 2(5):577-81. PubMed ID: 4797457
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic value of host immunocompetence in urologic cancer patients.
    Catalona WJ; Smolev JK; Harty JI
    J Urol; 1975 Dec; 114(6):922-6. PubMed ID: 1195475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of radial radiotherapy on delayed hypersensitivity and the inflammatory response.
    Ghossein NA; Bosworth JL; Bases RE
    Cancer; 1975 Jun; 35(6):1616-20. PubMed ID: 1148994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune evaluation with skin testing. A study of testicular, prostatic, and bladder neoplasms.
    Schellhammer PF; Bracken RB; Bean MA; Pinsky CM; Whitmore WF
    Cancer; 1976 Jul; 38(1):149-56. PubMed ID: 947511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoembryonic antigen in patients with urologic cancers.
    Guinan P; Ablin RJ; Barakat H; John T; Sadoughi N; Bush IM
    Urol Res; 1973 Oct; 1(3):101-5. PubMed ID: 4804082
    [No Abstract]   [Full Text] [Related]  

  • 10. Skin testing for prognosis or therapy formulation in cancer patients: caveat emptor.
    Mandel MA
    Plast Reconstr Surg; 1976 May; 57(5):621-6. PubMed ID: 1273144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cancer associated antigen test as an index to failure of complete removal of urological cancers.
    Wechsler M; Gerfo PL; Feminella J; Lattimer JK
    J Urol; 1973 Apr; 109(4):699-701. PubMed ID: 4735168
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic features of genitourinary cancer.
    Javadpour N
    Urology; 1973 Aug; 2(2):103-8. PubMed ID: 4129366
    [No Abstract]   [Full Text] [Related]  

  • 13. Colonic basophil hypersensitivity.
    Askenase PW; Boone WT; Binder HJ
    J Immunol; 1978 Jan; 120(1):198-301. PubMed ID: 627717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen and urothelial carcinoma.
    Hall RR; Laurence DJ; Neville AM; Wallace DM
    Br J Urol; 1973 Feb; 45(1):88-92. PubMed ID: 4690154
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunobiology of genitourinary tumors.
    Lange PH; Hakala TR; Fraley EE
    Urology; 1973 Nov; 2(5):485-92. PubMed ID: 4358375
    [No Abstract]   [Full Text] [Related]  

  • 16. An Overview of Emerging Immunotargets of Genitourinary Tumors.
    Montironi R; Santoni M; Cheng L; Lopez-Beltran A; Massari F; Matrana MR; Moch H; Scarpelli M
    Curr Drug Targets; 2016; 17(7):750-6. PubMed ID: 26648079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel immunotherapies in GU malignancies.
    Drakaki A; McDermott DF
    Curr Oncol Rep; 2013 Jun; 15(3):224-31. PubMed ID: 23519772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunology of genitourinary tumors.
    Guinan P; Sadoughi N; Bush IM; John T; Eghrari F; Ablin RJ
    Urology; 1973 Nov; 2(5):493-9. PubMed ID: 4131868
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunologic alterations in patients with prostatic carcinoma.
    Brosman S; Hausman M; Shacks S
    J Urol; 1975 Jun; 113(6):841-5. PubMed ID: 1152159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum immunoglobulins in genitourinary malignancies.
    Schmidt JD; Feldbush TL; Weinstein SH; Bonney WW
    J Urol; 1976 Mar; 115(3):293-5. PubMed ID: 943578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.